Safiglipron
Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects
Shandong Suncadia Medicine Co · Phase 2 · Completed · Enrollment 81
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Group A | Obesity or overweight | n/r | n/r | n/r | n/r |
| Group B | Obesity or overweight | n/r | n/r | n/r | n/r |
| Group C | Obesity or overweight | n/r | n/r | n/r | n/r |
| Group D | Obesity or overweight | n/r | n/r | n/r | n/r |